THETA Collaborative presents at the Society for Medical Decision Making (SMDM) 2017 - 39th Annual North American Meeting

Theme: Better Decisions Through Better Data Processes
Place: Pittsburgh, PA, US
Dates: October 22 - October 25, 2017
Tweet: #SMDM17


Incremental gains in science are often made by standing on the shoulders of giants. Now that scientific advancement is increasingly dependent on complex data systems (the present-day giant), robust procedures are necessary to ensure that insights from data are not obscured from future scientists and real-time users. The Society for Medical Decision Making has a long history of developing methodologies which take advantage of complex data structures to enhance medical decision making and advance policy formation. The 2017 Annual Meeting will explore themes to ensure the credibility and usability of our Society’s efforts and to promote our vision of an integrated approach to health care decision making, through wise use and thoughtful communication of data.(from SMDM 2017 website)

Symposium

Dr. Murray Krahn will be a moderator at the SMDM Symposium: Big Data for CEA and HTA, with two THETA inverstigators as panelists: Dr. Claire de Oliveira and Dr. Harindra C. Wijeysundera

Symposium: Big Data for CEA and HTA
Moderator: Dr. MD Krahn, Director of THETA Collaborative, the F. Norman Hughes Chair in Pharmacoeconomics and Social and Administrative Pharmacy Division Head in the Faculty of Pharmacy, Professor at the University of Toronto, and Scientist and Adjunct Scientist at the Toronto General Research Institute and Institute for Clinical Evaluative Sciences
Panelists:

  • Beate Sander, PhD, Scientist & Director, Population Health Economics Research (PHER), UHN; Director, Health Modeling & Health Economics, THETA Collaborative.
  • Robin Yabroff, Office of Health Policy, Assistant Secretary for Planning and Evaluation
  • Harindra C. Wijeysundera, Schulich Heart Center, Sunnybrook Health Sciences Center

Poster Abstracts

Cost-Utility Analysis of Upfront Pharmacotherapy Compared to an Upfront Surgical Intervention for Patients with Benign Prostate Hyperplasia 
Aysegul Erman, MSc, Lisa Masucci, MSc, Dean Elterman, MD, MSc, FRCPC, Murray Krahn, MD, MSc, FRCPC.

Creating a Map for the Road Less Traveled: Developing an Algorithm to Guide the Construction of a De Novo Condition-Specific Multi-Attribute Health Status Classification System
Teresa Tsui, MSc, Nicholas Mitsakakis, MSc PhD, Aileen Davis, PhD, Joanna M. Bielecki, BSc, MISt, Maureen Trudeau, MD, MA, FRCPC, Karen E Bremner, BSc, Murray Krahn, MD, MSc, FRCPC.

Estimation of Fibrosis Progression Rates for Chronic Hepatitis C: Updated Meta-Analysis and Meta-Regression
Aysegul Erman, MSc, Tawnya Hansen, MD, Joanna M. Bielecki, BSc, MISt, Jordan J. Feld, MD, MPH, Murray Krahn, MD, MSc, FRCPC, William W. L. Wong, PhD, Paul Grootendorst, PhD and Hla-Hla Thein, MD, MPH, PhD.

Exploring the Benefits of Transformations for the Analysis of Health Utility Data
Nicholas Mitsakakis, PhD, Karen E Bremner, BSc, George Tomlinson, PhD, Murray Krahn, MD, MSc, FRCPC.

Patient-Borne Costs Associated with Chronic Hepatitis C
Yasmin Saeed, BScPhm, Arcturus Phoon, Josephine F Wong, MD, Jordan J. Feld, MD, MPH, David Wong, MD, FRCP, Hemant Shah, MD, MScCH, Nicholas Mitsakakis, PhD, Valeria E. Rac, MD, PhD, Welson Ryan, Karen E Bremner, BSc, Murray Krahn, MD, MSc, FRCPC, William W. L. Wong, PhD.

Screening for Hepatitis C in the Emergency Department: A Cost-Effectiveness Analysis in Canada
Andrew Mendlowitz, MBiotech, HBSc, David Naimark, MD, MSc, BSc, William W. L. Wong, PhD, Wanrudee Isaranuwatchai, PhD, Murray Krahn, MD, MSc, FRCPC.

Applying the Expected Population Value of Quality Indicator Reporting Framework: An Example with Smoking Cessation in Chronic Obstructive Pulmonary Disease
Austin Nam, MSc, David Naimark, MD, MSc, BSc, Matthew Stanbrook, MD, PhD, FRCPC, FACP, Murray D. Krahn, MD, MSc, FRCPC.

Cost-Effectiveness Analysis of Annual Versus Biannual Ultrasound Surveillance for Hepatocellular Carcinoma in Patients with Hepatitis C Related Cirrhosis after Sustained Viral Response
Hooman Farhang Zangneh, William W. L. Wong, Beate Sander, Chaim M. Bell, Khalid Mumtaz, Matthew Kowgier, Adriaan J. van der Meer, Sean P. Cleary, Harry L. A. Janssen, Kelvin K. W. Chan, Jordan J. Feld.

Direct Healthcare Costs Associated with Nontuberculous Mycobacterial Infections in Ontario, Canada: A Population-Based Matched Cohort Study Using Laboratory and Health Administrative Data
Emily Shing, John Wang, Theodore Marras, Jeffrey Kwong, Sarah Brode, Frances Jamieson, Liane Macdonald, Beate Sander

The Cost-Effectiveness of a Pneumococcal Conjugate Vaccine (PCV13) Program for Older Adults (65+) in Ontario, Canada in the Context of Infant Immunization and Changing Serotype Distributions
Ryan O'Reilly, PhD (Candidate), Jeffrey Kwong, Allison McGeer, Beate Sander

The Cost-Effectiveness of a Targeted Clostridium Difficile Vaccination Program for Elective Surgery Patients in Ontario, Canada
Ryan O'Reilly, PhD (Candidate), Alainna Jamal, Nick Daneman, MD, MSc, Beate Sander, RN MBA MEcDev PhD

The Economic Burden of Pneumococcal Disease in the United States & Canada: A Systematic Review
Ryan O'Reilly, PhD (Candidate), Jeffrey Kwong, MD, MSc, CCFP, FRCPC, Allison McGeer, MD, FRCPC, Eleanor Pullenayegum, PhD, Beate Sander

Measles Control during Elimination: Is Current Public Health Action Worth the Effort?
Lauren Ramsay, Natasha Crowcroft, Shari Thomas, Elena Aruffo, Effie Gournis, Jane Heffernan, Valerie Jaeger, Manisa Jiaravuthisan, Jennifer Sharron, Alexandra Teslya, Shelley Deeks, Jonathan Gubbay, Joanne Hiebert, Tony Mazzulli, Alberto Severini, Beate Sander

Cost-Effectiveness Analysis of Novel High-Intensity Outpatient Stroke Rehabilitation Program at the Toronto Rehabilitation Institute in Ontario, Canada. Stephen Mac, Alan Tam, Wanrudee Isaranuwatchai, Mark Bayley

Posted on July 28, 2017